Press

23andMe gets FDA clearance for prostate cancer risk test

Genetics testing company 23andMe received Food and Drug Administration clearance for its prostate cancer risk test, the company announced today. It’s 23andMe’s third clearance for a cancer risk report — the company also has tests for genes that predict breast and colorectal cancer risk.

Read More

UserTesting Announces Pricing Of Initial Public Offering

UserTesting, Inc. (“UserTesting”), a leading provider of human insight, delivered through a video-first, experience testing platform, today announced the pricing of its initial public offering of 10,000,000 shares of common stock at a public offering price of $14.00 per share.

Read More

23andMe Agrees to Acquire Lemonaid Health

23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading consumer genetics and research company, today announced the signing of a definitive merger agreement with Lemonaid Health, Inc., an on-demand platform for accessing medical care and pharmacy services online.

Read More

UserTesting Files Registration Statement for Proposed Initial Public Offering

UserTesting, Inc. (“UserTesting”), a leading provider of human insight, delivered through a video-first, enterprise SaaS platform, today announced that it has publicly filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (“SEC”) relating to a proposed initial public offering of shares of its common stock.

Read More

Coursera Announces Pricing of Initial Public Offering

Coursera, Inc. (“Coursera”) today announced the pricing of its initial public offering of an aggregate of 15,730,000 shares of its common stock at a price to the public of $33.00 per share. The offering includes 14,664,776 shares of common stock to be issued and sold by Coursera and 1,065,224 shares of common stock to be sold by the selling stockholders.

Read More

ON24 Announces Pricing of Initial Public Offering

ON24, Inc. (NYSE:ONTF) today announced the pricing of its initial public offering of 8,560,930 shares of common stock at a price to the public of $50.00 per share. ON24 is offering 6,315,789 shares of common stock and certain selling stockholders are offering 2,245,141 shares of common stock.

Read More